A 3-year post-doc position is available in Pierre Guermonprez’s laboratory at Paris Diderot Medical School at the University of Paris. The goal of the project is to develop and evaluate a new cancer immunotherapy approach based on the manipulation of dendritic cells populations within the tumor micro-environment. The synergy between this novel approach and immune checkpoint blockade will be evaluated in pre-clinical murine models of cancer and humanized mice models.
Candidate profile:
-A Ph.D. with at least one first-authored publication is required.
-Technical experience with murine model and mammalian cell culture are required.
-Intellectual and/or technological expertise in one or several of the following areas will be appreciated: murine tumor models, humanized mice models, immunotherapy, in vivo imaging, mesenchymal stromal cells, macrophages, T lymphocytes, dendritic cells, tumor immunological microenvironment.
-Creativity, organization skills, and motivation for team work will be valued assets.
-Enthusiasm for research in translational immunology and cancer immunotherapy are essential.
Application’s deadline: August 30th 2021.
Start date: October/Novembre 2021.
To apply: Please send CV including publication list, a brief summary of research achievements, a cover letter and contact details of two references.
The AIDS Research Institute IrsiCaixa located in Hospital Germans Trias i Pujol in the Campus Can Ruti of Translational Research in Barcelona has an opening position in the group of Viral Immune evasion and vaccines (Virievac). The group is looking for a highly motivate Postdoctoral researcher to join the group working in the area of T cell immunity against virus (SARS-Co-V2 and HIV-1). Under the direction of the principal investigator but with a degree of independence the applicant will carry out activities for development of specific projects on T cell immunity. The candidate should have expertise in cellular immunology, good communication skills and scientific track record of publications.
Deadline 15th September 2021.